See also this year's filing and all EDGAR filings for this company.
PDF Report 0001589150_2022_Regen_BioPharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 2.6884322138701593e-06, 'aggregate_val': 371965, 'exp_sum': 371964, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 119495, 'ResearchAndDevelopmentExpense': 36704, 'remainder_Expenses': 215765}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001589150')"} |
Graph
Absolute values for 0001589150, Regen BioPharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 994,124 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 217,975 |
| 4 | LiabilitiesCurrent | 14,697,976 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 119,495 |
| 9 | ResearchAndDevelopmentExpense | 36,704 |
| 10 | remainder_Expenses | 215,766 |
| 11 | remainder_Revenues | 61,194 |
| 12 | remainder_NetIncome | -6,454,462 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,212,099 |
| 1 | Liabilities | 14,697,976 |
| 2 | Expenses | 371,965 |
| 3 | Revenues | 61,194 |
| 4 | StockholdersEquity | -13,485,877 |
| 5 | NetIncome | -6,765,233 |
| 6 | ComprehensiveNetIncome | -6,765,233 |
| 7 | BaseVar | 11,398,848 |
| 8 | EconomicCapitalRatio | -3.77 |
Edgar->Model Mapping
Feature Distribution
Change over Time
